We dont have equivalent high-quality data for fibromyalgia or EDS specifically, and the inflammatory profile in those conditions is different to the metabolic inflammation these studies were mostly looking at
By boosting cholinergic activity in the brain, ALCAR may help prevent cognitive decline and Alzheimers disease [36]
Current status: TRIUMPH-4 results available: December 2025 readout showing 28.7% weight loss at 68 weeks (Giblin et al., PMID 41090431) Additional TRIUMPH trials: Expected to report results through 2026, including TRIUMPH-Outcomes (cardiovascular endpoints, NCT06383390, completion Feb 2029) NDA submission timing: Eli Lilly must compile the full trial package before submitting
As appropriate, ANOVA and post hoc multiple comparisons or Student t-tests were performed as appropriate, with the significance threshold set at p 10%) were excluded from further testing
Description Details Dosage Research Questions PT-141 PT-141 is supplied for laboratory research workflows that require clear product identity, careful handling, and documented specifications